125 related articles for article (PubMed ID: 2678932)
1. [Carbamazepine: an effective adjuvant treatment in the schizophrenias].
Martín Muñoz JC; Moriñigo Domínguez AV; Mateo Martín I; Guajardo-Fajardo Ibarra I; Noval Lamos D
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1989; 17(4):245-50. PubMed ID: 2678932
[TBL] [Abstract][Full Text] [Related]
2. [Carbamazepine: an efficient adjuvant treatment in schizophrenia].
Martín Muñoz JC; Moriñigo Domínguez AV; Mateo Martín I; Guajardo-Fajardo Ibarra I; Noval Lamos D
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1992; 20(1):11-6. PubMed ID: 1502960
[TBL] [Abstract][Full Text] [Related]
3. [Comparative efficacy of bromocriptine, carbamazepine and cyproheptadine with neuroleptics in 24 refractory chronic schizophrenic patients].
Llorca PM; Wolf MA; Lançon C; Bougerol T
Encephale; 1993; 19(5):565-71. PubMed ID: 8306925
[TBL] [Abstract][Full Text] [Related]
4. Change in haloperidol level due to carbamazepine--a complicating factor in combined medication for schizophrenia.
Kahn EM; Schulz SC; Perel JM; Alexander JE
J Clin Psychopharmacol; 1990 Feb; 10(1):54-7. PubMed ID: 2106534
[TBL] [Abstract][Full Text] [Related]
5. Carbamazepine compared to haloperidol in acute mania.
Brown D; Silverstone T; Cookson J
Int Clin Psychopharmacol; 1989 Jul; 4(3):229-38. PubMed ID: 2794470
[TBL] [Abstract][Full Text] [Related]
6. Carbamazepine as an adjunct of antipsychotic therapy.
Dose M; Apelt S; Emrich HM
Psychiatry Res; 1987 Dec; 22(4):303-10. PubMed ID: 3324137
[TBL] [Abstract][Full Text] [Related]
7. Combined treatment of schizophrenic psychoses with haloperidol and valproate.
Dose M; Hellweg R; Yassouridis A; Theison M; Emrich HM
Pharmacopsychiatry; 1998 Jul; 31(4):122-5. PubMed ID: 9754845
[TBL] [Abstract][Full Text] [Related]
8. Effects of carbamazepine and valproate on haloperidol plasma levels and on psychopathologic outcome in schizophrenic patients.
Hesslinger B; Normann C; Langosch JM; Klose P; Berger M; Walden J
J Clin Psychopharmacol; 1999 Aug; 19(4):310-5. PubMed ID: 10440457
[TBL] [Abstract][Full Text] [Related]
9. Haloperidol in overt ambulatory schizophrenics.
Darling HF
Dis Nerv Syst; 1973; 34(7):364-7. PubMed ID: 4782293
[No Abstract] [Full Text] [Related]
10. Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study.
Klein E; Bental E; Lerer B; Belmaker RH
Arch Gen Psychiatry; 1984 Feb; 41(2):165-70. PubMed ID: 6365015
[TBL] [Abstract][Full Text] [Related]
11. Doubleblind evaluation of the antimanic properties of carbamazepine as a comedication to haloperidol.
Möller HJ; Kissling W; Riehl T; Bäuml J; Binz U; Wendt G
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):127-36. PubMed ID: 2664882
[TBL] [Abstract][Full Text] [Related]
12. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.
Marder SR; Davis JM; Chouinard G
J Clin Psychiatry; 1997 Dec; 58(12):538-46. PubMed ID: 9448657
[TBL] [Abstract][Full Text] [Related]
13. [Disagreement in standardized haloperidol treatment in comparison with "adequate individual dosage" of acutely schizophrenic patients].
Klieser E; Lehmann E
Fortschr Neurol Psychiatr; 1992 Mar; 60(3):126-9. PubMed ID: 1577361
[TBL] [Abstract][Full Text] [Related]
14. Acute and subchronic effects of low-dose bromocriptine in haloperidol-treated schizophrenics.
Gattaz WF; Rost W; Hübner CK; Bauer K
Biol Psychiatry; 1989 Feb; 25(3):247-55. PubMed ID: 2643996
[TBL] [Abstract][Full Text] [Related]
15. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
Zimbroff DL; Kane JM; Tamminga CA; Daniel DG; Mack RJ; Wozniak PJ; Sebree TB; Wallin BA; Kashkin KB
Am J Psychiatry; 1997 Jun; 154(6):782-91. PubMed ID: 9167505
[TBL] [Abstract][Full Text] [Related]
16. Amisulpride compared with standard neuroleptics in acute exacerbations of schizophrenia: three efficacy studies.
Freeman HL
Int Clin Psychopharmacol; 1997 May; 12 Suppl 2():S11-7. PubMed ID: 9218163
[TBL] [Abstract][Full Text] [Related]
17. [Extrapyamidal side-effects with 1-day dosage of haloperidol (author's transl)].
Matzner G; Uriarte V; Rüther E
Arzneimittelforschung; 1978; 28(9):1496-7. PubMed ID: 383097
[TBL] [Abstract][Full Text] [Related]
18. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.
Weisler RH; Kalali AH; Ketter TA;
J Clin Psychiatry; 2004 Apr; 65(4):478-84. PubMed ID: 15119909
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of haloperidol.
Man PL
Dis Nerv Syst; 1973 Feb; 34(2):113-8. PubMed ID: 4267586
[No Abstract] [Full Text] [Related]
20. Significantly higher plasma haloperidol level during cotreatment with carbamazepine may herald cardiac change.
Iwahashi K
Clin Neuropharmacol; 1996 Jun; 19(3):267-70. PubMed ID: 8726546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]